contributors
Last update [08/09/2008]
For-Profit Companies
The THEW Initiative aims at promoting cross-fertilization of scientific knowledge, resources and ideas that will advance the field of quantitative electrocardiography, the THEW will strive to:
- Facilitate scientific projects toward the development, testing and validation of ECG-related technologies and platforms;
- Leverage expertise and resources toward the implementation of collaborative projects among FDA, UR, and other public and private stakeholders;
- As appropriate, incorporate scientific findings from the THEW into the premarket evaluation process for electrocardiographic devices and associated methodologies, and into the total product life cycle.
Several private organizations have contributed to our intiative by joining the THEW Founding Donation Program. You will find the list of donators in the following table.
Company |
Founding Donation Program |
|---|---|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Not-For-Profit Companies/entities/individuals
The list of academic centers that have joined our initiative will be released soon.
[12/16/2009]: The Director of the THEW interviewed by Technology Review published by the MIT: here.
[11/11/2009]: New Research Center to Focus on Cardiac Safety and Innovation in Pharmaceutical Industry Today: here.
[6/11/2009]: University of of Rochester and FDA Partner for ECG Database, Drug Discovery & Development Magazine. More info here
[5/6/2009] FDA website Existing Partnerships FDA’s Public-Private Partnership Program: THEW
[03/28/2009] Public and Private part- nership to help determine Clinical Biomarker Utility in Applied Clinical Trials online.com.>here
[12/15/2009] Members: University of California and the San Francisco Campus (UCSF) has joined the Telemetric and Holter ECG Warehouse and its Center for Quantitative and Cardiac Safety. The collaborative arrangement has been triggered by the School of Nursing. UCSF School of Nursing was #1 in NIH research funding from 2003 to 2008 and was top ranked in US News America’s best Graduate School for 2007.
[11/16/2009] Technology: The THEW announces the release of its HL7 XML extraction tool. The THEW client application allows for ECG to be exported in HL7 XML ECGs, an ECG format broadly used in drug safety trials.
[05/27/2008] FDA: Dr. J. Woodcock (Director, CDER-FDA) and Dr. Norman Stockbridge (Director for the Division of Cardiovascular and Renal Products, CDER-FDA) signed a Letter of Agreement officially starting the partnership between the FDA and University of Rochester for the THEW initiative. More...
[05/27/2008]: "THEW Beyond QT working Group" releases an ECG marker submission form designed in collaboration with the FDA. More...